ARCHIVES

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of February

February 22, 2013

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Lynch Named Director, Yale Cancer Center

February 27, 2009

Publisher, Law Firm Settle Suit Over Newsletter Photocopy

November 15, 1991

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

NCI Advisory Group, Other Cancer Meetings

February 24, 1984